New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma

Jeffrey Schlom, Diane E. Milenic, Mario Roselli, David Colcher, Robert Bird, Syd Johnson, Karl D. Hardman, Fiorella Guadagni, John W. Greiner

Research output: Contribution to journalArticlepeer-review

Abstract

It is now generally agreed that while numerous monoclonal antibodies (MAbs) have been shown to efficiently target tumors in patients, much still needs to be accomplished to optimize MAb based tumor targeting and the use of MAbs in the therapy of human carcinoma. This article will review some recent studies undertaken in our laboratory in an attempt to generate novel recombinant constructs and test new principles to aid in optimizing MAb based diagnosis and therapy. Three areas will be covered: (a) the analysis of dose fractionation protocols; (b) the generation of recombinant/chimeric (rec/chi) MAbs including the generation of a single chain antigen binding protein (SCA); and (c) the use of recombinant interferons (rec IFNs) to selectively up-regulate tumor antigen expression. Each of these topics has been previously described in detail and appropriate references to these articles are included.

Original languageEnglish
JournalInternational Journal of Radiation Applications and Instrumentation.
Volume18
Issue number4
DOIs
Publication statusPublished - 1991

Fingerprint Dive into the research topics of 'New concepts in monoclonal antibody based radioimmunodiagnosis and radioimmunotherapy of carcinoma'. Together they form a unique fingerprint.

Cite this